Bavarian Nordic A/S ADR (BVNRY)

Currency in USD
10.51
+0.02(+0.21%)
Delayed Data·
BVNRY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.5010.51
52 wk Range
7.3113.00
Key Statistics
Prev. Close
10.49
Open
10.5
Day's Range
10.5-10.51
52 wk Range
7.31-13
Volume
2.07K
Average Vol. (3m)
3.08K
1-Year Change
39.4824%
Book Value / Share
25.87
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BVNRY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Bavarian Nordic A/S ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV, that is in phase 2 trial for the treatment of encephalitis viruses. It operates in the United States, Denmark, Canada, France, Germany, Singapore, England, Finland, Switzerland, Japan, Austria, Italy, Spain, Taiwan, Saudi Arabia, Australia, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.

Employees
1692

Compare BVNRY to Peers and Sector

Metrics to compare
BVNRY
Peers
Sector
Relationship
P/E Ratio
11.2x14.1x−0.5x
PEG Ratio
0.280.070.00
Price / Book
1.2x4.0x2.6x
Price / LTM Sales
2.5x2.4x3.2x
Upside (Analyst Target)
-75.1%47.6%
Fair Value Upside
Unlock8.6%6.1%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 12, 2026
EPS / Forecast
-4.13 / --
Revenue / Forecast
1.45B / --
EPS Revisions
Last 90 days

BVNRY Income Statement

People Also Watch

27.560
MKKGY
+0.55%
32.21
CZMWY
+1.13%
54.35
CGNX
-2.21%
156.28
UCBJY
-1.98%
54.14
TEM
+9.30%

FAQ

What Is the Bavarian Nordic ADR (BVNRY) Stock Price Today?

The Bavarian Nordic ADR stock price today is 10.51 USD.

What Stock Exchange Does Bavarian Nordic ADR Trade On?

Bavarian Nordic ADR is listed and trades on the OTC Markets.

What Is the Stock Symbol for Bavarian Nordic ADR?

The stock symbol for Bavarian Nordic ADR is "BVNRY."

What Is the Bavarian Nordic ADR Market Cap?

As of today, Bavarian Nordic ADR market cap is 2.44B USD.

What Is Bavarian Nordic ADR's Earnings Per Share (TTM)?

The Bavarian Nordic ADR EPS (TTM) is 17.60.

From a Technical Analysis Perspective, Is BVNRY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bavarian Nordic ADR Stock Split?

Bavarian Nordic ADR has split 1 times.

How Many Employees Does Bavarian Nordic ADR Have?

Bavarian Nordic ADR has 1692 employees.

What is the current trading status of Bavarian Nordic ADR (BVNRY)?

As of Apr 15, 2026, Bavarian Nordic ADR (BVNRY) is trading at a price of 10.51 USD, with a previous close of 10.49 USD. The stock has fluctuated within a day range of 10.50 USD to 10.51 USD, while its 52-week range spans from 7.31 USD to 13.00 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.